Point72 Asset Management Portfolio holdings
AUM
$46B
1-Year Est. Return
32.29%
1 Year Est. Return
+32.29%
AUM
$42.3B
AUM Growth
+$6.67B
(+19%)
Holding
1,958
Top Buys
| 1 | +$684M | |
| 2 | +$518M | |
| 3 | +$481M | |
| 4 |
Snowflake
SNOW
|
+$445M |
| 5 |
Biogen
BIIB
|
+$430M |
Top Sells
| 1 | +$311M | |
| 2 | +$289M | |
| 3 | +$278M | |
| 4 |
Vistra
VST
|
+$261M |
| 5 |
MACOM Technology Solutions
MTSI
|
+$250M |
Sector Composition
| 1 | Technology | 29.75% |
| 2 | Healthcare | 16.12% |
| 3 | Consumer Discretionary | 14.29% |
| 4 | Industrials | 8.23% |
| 5 | Financials | 5.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Chubb
CB
$121B
| $23.3M | 0.05% |
+80,321
|
|
||
352
Vontier
VNT
$5.38B
| $23.2M | 0.05% |
629,400
+68,979
|
|
||
353
Vulcan Materials
VMC
$39.1B
| $23.1M | 0.05% |
88,618
+51,761
|
|
||
354
ICF International
ICFI
$1.61B
| $23.1M | 0.05% |
+272,793
|
|
||
355
Willis Towers Watson
WTW
$31.3B
| $22.7M | 0.04% |
74,170
+38,367
|
|
||
356
Warner Music
WMG
$14.5B
| $22.6M | 0.04% |
+830,940
|
|
||
|
ETNB
357
DELISTED
89bio
ETNB
| $22.3M | 0.04% |
+2,274,151
|
|
||
|
CHYM
358
Chime Financial
CHYM
$9.81B
| $22.3M | 0.04% |
+645,933
|
|
||
359
Fortive
FTV
$17.4B
| $22.2M | 0.04% |
426,700
+385,587
|
|
||
360
Pentair
PNR
$17.3B
| $22.1M | 0.04% |
215,648
-330,272
|
|
||
361
Nu Holdings
NU
$81.9B
| $22M | 0.04% |
+1,606,186
|
|
||
362
Avantor
AVTR
$7.62B
| $22M | 0.04% |
+1,636,640
|
|
||
363
MakeMyTrip
MMYT
$7.86B
| $22M | 0.04% |
+224,622
|
|
||
364
CME Group
CME
$98.6B
| $21.9M | 0.04% |
79,556
-110,755
|
|
||
365
Toyota
TM
$271B
| $21.7M | 0.04% |
+126,250
|
|
||
366
US Physical Therapy
USPH
$1.23B
| $21.6M | 0.04% |
275,710
+94,972
|
|
||
367
RadNet
RDNT
$5.71B
| $21.4M | 0.04% |
376,195
+241,764
|
|
||
368
KBR
KBR
$5.52B
| $21.4M | 0.04% |
446,000
-195,598
|
|
||
369
Hallador Energy
HNRG
$977M
| $21.2M | 0.04% |
1,341,206
+179,517
|
|
||
370
Avient
AVNT
$2.83B
| $21.1M | 0.04% |
652,061
+225,676
|
|
||
371
Bank OZK
OZK
$5.45B
| $21M | 0.04% |
447,200
+124,562
|
|
||
372
Gildan
GIL
$11.2B
| $20.9M | 0.04% |
+424,200
|
|
||
373
Arcutis Biotherapeutics
ARQT
$3.55B
| $20.8M | 0.04% |
1,485,425
+654,947
|
|
||
|
HSAI
374
Hesai Group
HSAI
$3.2B
| $20.8M | 0.04% |
948,458
+782,909
|
|
||
375
ADC Therapeutics
ADCT
$524M
| $20.8M | 0.04% |
+7,763,658
|
|